Alector (ALEC) Change in Acquisitions & Divestments (2018 - 2026)
Alector's (ALEC) quarterly Change in Acquisitions & Divestments came in at $45.0 million in Q2 2026, down 65.07% year-over-year from $128.8 million in Q2 2025, and down 60.13% quarter-over-quarter from $112.9 million in Q1 2026.
Analysis
Alector (ALEC) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Change in Acquisitions & Divestments for 9 consecutive years, with $45.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 65.07% year-over-year to $45.0 million in Q2 2026; TTM through Jun 2026 was $373.0 million, a 25.66% decrease from a year earlier, with the FY2025 full-year figure at $465.5 million, down 18.83% from the prior year.
- Change in Acquisitions & Divestments was $45.0 million for Q2 2026 at Alector, down from $112.9 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $210.0 million in Q1 2023 and troughed at $18.7 million in Q1 2022.
- A 5-year average of $125.1 million and a median of $127.6 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The widest YoY moves for Change in Acquisitions & Divestments: up 1166.36% in 2022, down 83.08% in 2022.
- Over 5 years, Change in Acquisitions & Divestments stood at $181.7 million in 2022, then decreased by 16.32% to $152.0 million in 2023, then slipped by 16.16% to $127.5 million in 2024, then declined by 16.35% to $106.6 million in 2025, then plunged by 57.8% to $45.0 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $45.0 million (Q2 2026), $112.9 million (Q1 2026), and $106.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.00 Mn |
| Mar 31, 2026 | 112.87 Mn |
| Dec 31, 2025 | 106.65 Mn |
| Sep 30, 2025 | 108.51 Mn |
| Jun 30, 2025 | 128.84 Mn |
| Mar 31, 2025 | 121.55 Mn |
| Dec 31, 2024 | 127.49 Mn |
| Sep 30, 2024 | 123.91 Mn |
| Jun 30, 2024 | 136.93 Mn |
| Mar 31, 2024 | 185.23 Mn |
| Dec 31, 2023 | 152.05 Mn |
| Sep 30, 2023 | 162.84 Mn |
| Jun 30, 2023 | 127.63 Mn |
| Mar 31, 2023 | 210.00 Mn |
| Dec 31, 2022 | 181.70 Mn |
| Sep 30, 2022 | 135.50 Mn |
| Jun 30, 2022 | 66.10 Mn |
| Mar 31, 2022 | 18.70 Mn |
| Dec 31, 2021 | 57.49 Mn |
| Sep 30, 2021 | 10.70 Mn |